Proinsulin peptide C19-A3 immunotherapy in new-onset type 1 diabetes is well-tolerated and associated with reduced total daily insulin usage

Related Event
ABCD Spring Meeting 2019

File(s)

Proinsulin peptide C19-A3 immunotherapy in new-onset type 1 diabetes is well-tolerated and associated with reduced total daily i

Discipline

Diabetes

Resource taxonomy

Event resources Slides

Clinical taxonomy

Treatments for diabetes Type 1 diabetes mellitus

Listing status

Current